novel transcript, antisense to ANKH

Novel transcript, antisense to ANKH" refers to a non-coding RNA expressed from the genomic region opposite to the ANKH gene (ANKH Inorganic Pyrophosphate Transport Regulator). While antisense transcripts are widespread in the human genome and can regulate the expression of their associated sense genes by altering chromatin states and transcriptional dynamics[3][5], there is no evidence that this antisense transcript is a therapeutic target or is directly involved in any recognized disease process. Its sequence is listed in bioinformatic databases but not characterized functionally or clinically. Antisense transcription more broadly can modulate chromatin, alter the stability and processing of sense transcripts, and may buffer gene expression, but these phenomena are general properties and not specific to this uncharacterized transcript[3][5]. Key Points: - This entry does *not* correspond to a canonical therapeutic target. - It is a computationally defined antisense long non-coding transcript with no current evidence of functional protein coding, receptor activity, or disease association. - There is *nothing about this target that would identify it as a receptor, enzyme, transporter, etc.*—it is likely annotated automatically in the Human Genome Project or Ensembl transcript databases. If you are seeking information on "ANKH" itself, that is a **protein-coding gene encoding a pyrophosphate transporter** involved in bone mineralization, but the antisense transcript is not equivalent to the ANKH protein[1][2][4][6].

Other names

ENSG00000286970antisense transcript to ANKH